Literature DB >> 6498583

Dopamine reverses cardiovascular depression of toxic doses of pentobarbitone in dogs.

C Roesch, K A Haselby, R R Paradise, G Krishna, S Dierdorf, T M Wolfe, C C Rao.   

Abstract

Pentobarbitone, 20 mg X kg-1 IV followed by infusion of 25 mg X kg-1 X hr-1, produced a progressive decrease in mean arterial pressure in dogs from 113 +/- 17 mmHg (SD) after one hour of infusion to 82 +/- 21 mmHg after 3.5 hours and to 49 +/- 22 mmHg after 5.5 hours. EEG silence occurred at 3.6 +/- 0.6 hours. In dogs similarly treated with pentobarbitone, a two hour infusion of dopamine 5 micrograms X kg-1 X min-1 beginning at the time of EEG silence prevented the further decrease in pressure and restored pressure to 87 +/- 18 mmHg. The mechanism for this effect of dopamine was an increase in cardiac output as systemic vascular resistance was unaffected by dopamine. The cardiac output increase was mainly the result of an increase in stroke volume as heart rate increased only slightly. Since reduced stroke volume was the main reason why pentobarbitone lowered blood pressure, the effect of dopamine on stroke volume and thus on blood pressure makes it an appropriate antagonist to the cardiovascular effects of toxic doses of pentobarbitone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6498583     DOI: 10.1007/bf03008763

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  16 in total

Review 1.  Intracranial hypertension: therapeutic and anesthetic considerations.

Authors:  H M Shapiro
Journal:  Anesthesiology       Date:  1975-10       Impact factor: 7.892

2.  A PROPOSED MECHANISM FOR THE DEPRESSOR EFFECT OF DOPAMINE IN THE ANESTHETIZED DOG.

Authors:  J N EBLE
Journal:  J Pharmacol Exp Ther       Date:  1964-07       Impact factor: 4.030

3.  The dopamine vascular receptor.

Authors:  L I Goldberg
Journal:  Biochem Pharmacol       Date:  1975-03-15       Impact factor: 5.858

4.  Increased clearances of phenobarbital and salicylate produced by dopamine in the dog.

Authors:  R R Gifford; H T Brock; P G Dayton; L I Goldberg
Journal:  Am J Med Sci       Date:  1969-11       Impact factor: 2.378

5.  Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog.

Authors:  C B Higgins; R W Millard; E Braunwald; S F Vatner
Journal:  Am J Physiol       Date:  1973-08

6.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

7.  Enflurane depresses myocardial function, perfusion, and metabolism in the dog.

Authors:  R G Merin; T Kumazawa; N L Luka
Journal:  Anesthesiology       Date:  1976-11       Impact factor: 7.892

8.  The pulmonary and systemic circulatory response to dopamine infusion.

Authors:  D C Harrison; S Pirages; S C Robison; B U Wintroub
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

9.  Comparison of cardiovascular effects of thiopental and pentobarbital at equivalent levels of CNS depression.

Authors:  C Roesch; K A Haselby; R R Paradise; G Krishna; S Dierdorf; T M Wolfe; C C Rao
Journal:  Anesth Analg       Date:  1983-08       Impact factor: 5.108

10.  Pentobarbital therapy for intracranial hypertension in metabolic coma. Reye's syndrome.

Authors:  L F Marshall; H M Shapiro; A Rauscher; N M Kaufman
Journal:  Crit Care Med       Date:  1978 Jan-Feb       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.